Literature DB >> 24450760

Faecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae is common 12 months after infection and is related to strain factors.

E Titelman1, C M Hasan, A Iversen, P Nauclér, M Kais, M Kalin, C G Giske.   

Abstract

We aimed to determine the duration of faecal carriage of extended-spectrum β-lactamase (ESBL) -producing Enterobacteriaceae (EPE) in patients with clinical infection caused by an EPE, to study host strains during carriage, and to identify factors associated with prolonged carriage. Patients (n = 61) were followed with faecal samples and questionnaires about antimicrobial treatment and risk factors for EPE, 1, 3, 6 and 12 months after EPE infection. The EPE isolates were subjected to ESBL genotyping, epidemiological typing with pulsed-field gel electrophoresis and PCR-based replicon typing. Escherichia coli isolates were analysed with PCR for phylogrouping, detection of pabB (ST131) and virulence content. Patient-related and strain-related variables were compared for carriers and non-carriers at 12 months. Carriage of EPE was observed in 51 of 61 (84%) patients after 1 month, 36 of 61 (66%) after 3 months, 31 of 61 (55%) after 6 months and 26 of 61 (43%) after 12 months. Of the 26 carriers at 12 months, five had previous negative samples. In 17 of 61 patients, ESBL was found in a new bacterial species and/or strain during carriage. Among E. coli, 14 of 49 belonged to the international clone ST131. Phylogroup B2 and CTX-M-gr.-9 were associated with being carriers at 12 months (OR 4.3, 95% CI 1.1-16.3 and OR 6.4, 95% CI 1.3-30.9, respectively). In conclusion, EPE carriage is common 12 months after infection and persisting carriage may be associated with E. coli phylogroup B2 and CTX-M-gr.-9. The host strain frequently changes throughout carriage and negative samples do not imply eliminated carriage.
© 2014 The Authors Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Keywords:  CTX-M-15; ST131; extended-spectrum β-lactamase; phylogroup B2; stool colonization

Mesh:

Substances:

Year:  2014        PMID: 24450760     DOI: 10.1111/1469-0691.12559

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  25 in total

1.  High Heterogeneity of Multidrug-Resistant Enterobacteriaceae Fecal Levels in Hospitalized Patients Is Partially Driven by Intravenous β-Lactams.

Authors:  Eva M González-Barberá; Jaime Sanz; Ana Djukovic; Alejandro Artacho; Iván Peñaranda; Beatriz Herrera; María José Garzón; Miguel Salavert; José Luis López-Hontangas; Karina B Xavier; Bernhard Kuster; Laurent Debrauwer; Jean-Marc Rolain; Miguel A Sanz; Joao B Xavier; Carles Ubeda
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191

2.  Persistence of colonisation with MDRO following discharge from the ICU.

Authors:  Jean-Christophe Lucet; Despoina Koulenti; Jean-Ralph Zahar
Journal:  Intensive Care Med       Date:  2014-03-08       Impact factor: 17.440

3.  Editorial Commentary: Fecal ESBL Screening: Are We Ready for This Information?

Authors:  Sarah E Turbett; Michael K Mansour
Journal:  Clin Infect Dis       Date:  2016-05-03       Impact factor: 9.079

4.  Long-Term Carriage of Ciprofloxacin-Resistant Escherichia coli Isolates in High-Risk Nursing Home Residents.

Authors:  Miriam D Ismail; Ting Luo; Sara McNamara; Bonnie Lansing; Evonne Koo; Lona Mody; Betsy Foxman
Journal:  Infect Control Hosp Epidemiol       Date:  2016-01-19       Impact factor: 3.254

5.  The impact of the ST131 clone on recurrent ESBL-producing E. coli urinary tract infection: a prospective comparative study.

Authors:  Anna Lindblom; Camilla Kiszakiewicz; Erik Kristiansson; Shora Yazdanshenas; Nina Kamenska; Nahid Karami; Christina Åhrén
Journal:  Sci Rep       Date:  2022-06-16       Impact factor: 4.996

6.  Duration of rectal colonization with extended-spectrum beta-lactamase-producing Escherichia coli: results of an open, dynamic cohort study in Dutch nursing home residents (2013-2019).

Authors:  Veronica Weterings; Wouter van den Bijllaardt; Martin Bootsma; Yvonne Hendriks; Linda Kilsdonk; Ans Mulders; Jan Kluytmans
Journal:  Antimicrob Resist Infect Control       Date:  2022-07-15       Impact factor: 6.454

7.  Long-Term Colonization by bla(CTX-M)-Harboring Escherichia coli in Healthy Japanese People Engaged in Food Handling.

Authors:  Kunihiko Nakane; Kumiko Kawamura; Kensuke Goto; Yoshichika Arakawa
Journal:  Appl Environ Microbiol       Date:  2016-01-08       Impact factor: 4.792

8.  Colonisation with ESBL-producing and carbapenemase-producing Enterobacteriaceae, vancomycin-resistant enterococci, and meticillin-resistant Staphylococcus aureus in a long-term care facility over one year.

Authors:  Catherine Ludden; Martin Cormican; Akke Vellinga; James R Johnson; Bernie Austin; Dearbháile Morris
Journal:  BMC Infect Dis       Date:  2015-04-01       Impact factor: 3.090

9.  Identity of blaCTX-M Carrying Plasmids in Sequential ESBL-E. coli Isolates from Patients with Recurrent Urinary Tract Infections.

Authors:  Nahid Karami; Sriram Kk; Shora Yazdanshenas; Yii-Lih Lin; Daniel Jaén-Luchoro; Elina Ekedahl; Sanjana Parameshwaran; Anna Lindblom; Christina Åhrén; Fredrik Westerlund
Journal:  Microorganisms       Date:  2021-05-25

10.  A trial with IgY chicken antibodies to eradicate faecal carriage of Klebsiella pneumoniae and Escherichia coli producing extended-spectrum beta-lactamases.

Authors:  Anna-Karin Jonsson; Anders Larsson; Thomas Tängdén; Åsa Melhus; Anders Lannergård
Journal:  Infect Ecol Epidemiol       Date:  2015-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.